These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8470323)

  • 21. ["BCGitis", a systemic complication of intravesical BCG therapy of bladder tumor].
    Sicard D; Steg A; Leleu C; Boccaccio F; Abadia R; Tulliez M; Cremer GA
    Ann Med Interne (Paris); 1987; 138(7):555-6. PubMed ID: 3439677
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of combined intravesical immunotherapy and chemotherapy for non-muscle invasive bladder cancer.
    Hilton WM; Ercole B; Parekh DJ; Sonpavde G; Ghosh R; Svatek RS
    Expert Rev Anticancer Ther; 2011 Jun; 11(6):949-57. PubMed ID: 21707292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New approaches to intravesical chemo-immunotherapy in superficial bladder cancer.
    van der Meijden AP
    Prog Clin Biol Res; 1992; 378():95-101. PubMed ID: 1301591
    [No Abstract]   [Full Text] [Related]  

  • 24. Quadruple immunotherapy of Bacillus Calmette-Guérin, interferon, interleukin-2, and granulocyte-macrophage colony-stimulating factor as salvage therapy for non-muscle-invasive bladder cancer.
    Steinberg RL; Nepple KG; Velaer KN; Thomas LJ; O'Donnell MA
    Urol Oncol; 2017 Dec; 35(12):670.e7-670.e14. PubMed ID: 28801026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Miliary pulmonary tuberculosis after the first dose of intravesical BCG instillation in a patient with high-grade bladder cancer.
    Stępień A; Brudło M; Stachura T; Marcinek P; Soja J; Sładek K
    Adv Respir Med; 2020; 88(6):628-629. PubMed ID: 33393659
    [No Abstract]   [Full Text] [Related]  

  • 26. [Nonspecific immunotherapy with BCG vaccine in bladder tumors].
    Damianov Kh; Patrashkov T; Petkov Ts; Tonchev T; Petrov P
    Khirurgiia (Sofiia); 1990; 43(1):48-53. PubMed ID: 2395285
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reactive arthritis following BCG immunotherapy for urinary bladder carcinoma: a systematic review.
    Tinazzi E; Ficarra V; Simeoni S; Artibani W; Lunardi C
    Rheumatol Int; 2006 Apr; 26(6):481-8. PubMed ID: 16220289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pulmonary disease following intravesical BCG treatment.
    Kesten S; Title L; Mullen B; Grossman R
    Thorax; 1990 Sep; 45(9):709-10. PubMed ID: 2218978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravesical bacillus Calmette-Guérin (BCG) in superficial bladder tumors. An overview.
    Debruyne FM; Witjes JA; vd Meijden AP
    Arch Esp Urol; 1990; 43 Suppl 2():133-8. PubMed ID: 2096774
    [No Abstract]   [Full Text] [Related]  

  • 30. Cystoprostatectomy and orthotopic ileal neobladder reconstruction for management of bacille Calmette Guérin-induced bladder contractures.
    Nieder AM; Sved PD; Stein JP; Skinner DG; Soloway MS
    Urology; 2005 May; 65(5):909-12. PubMed ID: 15882722
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypersensitivity systemic reaction following intravesical bacillus Calmette-Guerin: successful treatment with steroids.
    Molina JM; Rabian C; D'Agay MF; Modai J
    J Urol; 1992 Mar; 147(3):695-7. PubMed ID: 1538462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravesical BCG therapy in patients with superficial bladder tumors.
    Steg A; Belas M; Leleu C; Boccon-Gibod L
    Prog Clin Biol Res; 1989; 310():153-60. PubMed ID: 2771990
    [No Abstract]   [Full Text] [Related]  

  • 33. Miliary tuberculosis after intravesical bacille Calmette-Guérin immunotherapy for carcinoma of the bladder.
    Rabe J; Neff KW; Lehmann KJ; Mechtersheimer U; Georgi M
    AJR Am J Roentgenol; 1999 Mar; 172(3):748-50. PubMed ID: 10063874
    [No Abstract]   [Full Text] [Related]  

  • 34. The fate of bacillus Calmette-Guerin after intravesical instillation.
    Durek C; Richter E; Basteck A; Rüsch-Gerdes S; Gerdes J; Jocham D; Böhle A
    J Urol; 2001 May; 165(5):1765-8. PubMed ID: 11342972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Squamous cell carcinoma of bladder after successful intravesical therapy with Bacillus Calmette-Guérin.
    Brenner DW; Yore LM; Schellhammer PF
    Urology; 1989 Aug; 34(2):93-5. PubMed ID: 2763404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicenter study of the BCG Tokyo strain for intravesical treatment in patients with superficial bladder cancer. BCG Study Group.
    Aso Y; Akaza H; Kameyama S; Niijima T
    Prog Clin Biol Res; 1989; 303():383-91. PubMed ID: 2675000
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intravesical immunotherapy with BCG vaccine in superficial carcinoma of the urinary bladder].
    Pacík D; Vít V; Turjanica M
    Rozhl Chir; 1997 Oct; 76(10):482-5. PubMed ID: 9471737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reactive arthritis after the intravesical instillation of BCG.
    Macía Villa C; Sifuentes Giraldo W; Boteanu A; González Lanza M; Bachiller Corral J
    Reumatol Clin; 2012; 8(5):284-6. PubMed ID: 22377450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polymyalgia rheumatica with temporal arteritis following intravesical Calmette-Guérin bacillus immunotherapy for bladder cancer.
    Genereau T; Koeger AC; Chaïbi P; Bourgeois P
    Clin Exp Rheumatol; 1996; 14(1):110. PubMed ID: 8697650
    [No Abstract]   [Full Text] [Related]  

  • 40. Bilateral panuveitis following intravesical BCG immunotherapy for bladder carcinoma.
    Uppal GS; Shah AN; Tossounis CM; Tappin MJ
    Ocul Immunol Inflamm; 2010 Aug; 18(4):292-6. PubMed ID: 20662661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.